Overview of the 2018 US Food and Drug Administration Circulatory System Devices Panel Meeting on Device-Based Therapies for hypertension.

• Hypertension is the leading preventable cause of MI, stroke, and death worldwide. • FDA's Circulatory System Devices Panel discussed device-based management of HTN • Device targets include RDN, baroreflex amplification and hemodynamic modification. • Summary of published data and ongoing randomized clinical trials is presented. • Panel and industry supported renaissance of device-based antihypertensive therapies [ABSTRACT FROM AUTHOR]